Three preclinical models: melanoma (B16), breast cancer (4T1) and colon cancer (MC-38), and their corresponding cancer therapy: adoptive T cell transfer, AC-T chemotherapy, and anti-PD-1 immunotherapy were used. Here, PDCD1 is linked to malignant colon neoplasm.